新发房颤对冠状动脉旁路移植术后病因特异性晚期死亡率的影响
该研究分析8807例非挽救性冠状动脉旁路移植患者(1994-2011),比较术后新发房颤(POAF)与无POAF患者的15年及分时段全因和病因特异性死亡率。POAF发生率为23%,与更高的调整全因死亡(AHR 1.23,95%CI 1.14-1.33)和复合心脑血管死亡(AHR 1.15,95%CI 1.02-1.30)相关,脑血管死亡和Non-CV死亡趋势未达显著;分时段分析显示POAF在中期增加脑血管死亡(AHR 2.14,95%CI 1.14-4.04)和复合心脑血管死亡(AHR 1.31,95%CI 1.06-1.62),Non-CV死亡各时段均相似。结论认为POAF与较差的长期生存相关,主要由中期脑血管和心血管死亡增加驱动。
要点
- POAF发生率为23%(1992/8807例)。
- POAF与调整全因死亡(AHR 1.23,95%CI 1.14-1.33)和复合心脑血管死亡(AHR 1.15,95%CI 1.02-1.30)升高相关。
- 中期脑血管死亡(AHR 2.14,95%CI 1.14-4.04)和复合心脑血管死亡(AHR 1.31,95%CI 1.06-1.62)升高,Non-CV死亡各时段相似。
核心结论
- POAF与较差的长期生存相关,主要由中期脑血管和心血管死亡增加驱动,而Non-CV死亡相似。
研究设计与样本
- 回顾性分析8807例非挽救性冠状动脉旁路移植患者(1994-2011),比较POAF与无POAF患者的15年及分时段(早期0-1年、中期1-6年、晚期6-15年)全因和病因特异性死亡率,采用竞争风险Cox回归计算调整风险比。
主要发现
- POAF发生于1992例(23%)患者,非POAF并发症在POAF患者中更频繁(31% vs 18%;P < 0.001)。
- 总体平均随访9 ± 4年,POAF患者15年未调整死亡率更高(53% vs 39%;P < 0.001)。
- POAF与更高的调整全因死亡(AHR 1.23,95%CI 1.14-1.33)和复合心脑血管死亡(AHR 1.15,95%CI 1.02-1.30)相关。
- 15年脑血管死亡(AHR 1.34,95%CI 0.94-1.91)和Non-CV死亡(AHR 1.12,95%CI 0.99-1.26)趋势未达统计学显著。
- 分时段分析显示POAF在中期增加脑血管死亡(AHR 2.14,95%CI 1.14-4.04)和复合心脑血管死亡(AHR 1.31,95%CI 1.06-1.62),早期和晚期未增加;Non-CV死亡各时段相似。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: Postoperative atrial fibrillation (POAF) is a common complication after coronary artery bypass grafting. Although transient, POAF is linked to increased late mortality. We hypothesized that POAF increases late cerebrovascular (CeV) and composite cerebrovascular/cardiovascular/vascular (CV* = CeV + CV + Other-V) but not non-cardiovascular (Non-CV) mortality. METHODS: We analysed 8807 non-salvage coronary artery bypass grafting patients (1994-2011). Fifteen-year and time-segmented (early, 0-1 year; intermediate, 1-6 years and late, 6-15 years) all-cause and cause-specific mortality were compared for POAF versus No-POAF patients. Corresponding POAF versus No-POAF adjusted hazard ratios [AHRs (95% confidence interval, CI)] were derived using the competing risk Cox regression. RESULTS: POAF occurred in 1992 (23%) patients. Complications other than POAF occurred in 1875 (21%) patients but were more frequent among POAF patients (31% vs 18%; P < 0.001). Overall mean follow-up was 9 ± 4 years. POAF patients had a higher 15-year unadjusted mortality (53% vs 39%; P < 0.001) and were consequently associated with higher adjusted all-cause [AHR (95% CI) = 1.23 (1.14-1.33)] and composite cardiovascular [CV*: AHR (95% CI) = 1.15 (1.02-1.30)] mortality. The trends towards a higher 15-year CeV [AHR (95% CI) = 1.34 (0.94-1.91)] and Non-CV [AHR (95% CI) = 1.12 (0.99-1.26)] mortality were not significant. Time-segmented analyses showed that (i) POAF increased all-cause mortality early, and this persisted in the intermediate and late periods and (ii) CeV [AHR (95% CI) = 2.14 (1.14-4.04)] and CV* [AHR (95% CI) = 1.31 (1.06-1.62)] mortality rates were increased in the intermediate but not in the early or late periods. Non-CV mortality was similar in POAF and No-POAF for all time intervals. These findings were corroborated in propensity-matched sub-cohorts and in sensitivity analyses in patients free of any other complication. CONCLUSIONS: POAF is associated with worse long-term survival principally driven by increased intermediate-term cerebrovascular and cardiovascular mortality, while Non-CV mortality was similar.
引用
- Schwann TA, Al-Shaar L, Engoren MC, et al. Effect of new-onset atrial fibrillation on cause-specific late mortality after coronary artery bypass grafting surgery. Eur J Cardiothorac Surg. 2018. PMID: 29481591. doi:10.1093/ejcts/ezy028
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。